Novel mutation in STXBP2 prevents IL-2-induced natural killer cell cytotoxicity

J Allergy Clin Immunol. 2012 Jun;129(6):1666-8. doi: 10.1016/j.jaci.2011.12.1003. Epub 2012 Feb 14.

Abstract

We have identified dizygotic twins with a novel syntaxin-binding protein 2 (STXBP2) mutation, where cytotoxicity cannot be restored with IL-2. This defines STXBP2 as an absolute requirement for NK cell cytotoxic function.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cell Line
  • Cytotoxicity, Immunologic* / drug effects
  • Humans
  • Infant
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Lymphohistiocytosis, Hemophagocytic / diagnosis
  • Lymphohistiocytosis, Hemophagocytic / genetics*
  • Lymphohistiocytosis, Hemophagocytic / immunology*
  • Male
  • Munc18 Proteins / genetics*
  • Mutation*
  • Pedigree
  • Twins, Dizygotic

Substances

  • Interleukin-2
  • Munc18 Proteins
  • STXBP2 protein, human